November 10, 2021

Removing Race from Kidney Disease Diagnosis

Over the past year and a half, the NKF and ASN have been leading the effort to develop race-free eGFR test results while maintaining the accuracy of the test. The NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases has recently released its final report that recommends a new, race-free approach to estimate eGFR. In this collaborative episode with the ASN, the Task Force discusses how they approached the work and what efforts are being made to ensure the new equation is implemented as quickly as possible. Our guests, Dr. Cynthia Delgado, Dr. Lesley Inker, Dr. Joe Vassalotti and Tod Ibrahim discuss the goals of the Task Force and how the healthcare team came together to come up with a solution that better served kidney patients. They discuss the implications for patients, how clinicians and researchers can adopt these new guidelines, and what resources are available for both patients and the medical community to learn more.


Developed in accordance with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and recommended by the National Kidney Foundation and American Society of Nephrology Task Force Reassessing the Inclusion of Race in Diagnosing Kidney Diseases, the new app is available for free by visiting the NKF website. 


If you enjoyed this episode, please follow us on Apple Podcasts, Spotify, Podbean or wherever you listen to your podcasts. Have ideas for future episodes? Email us at or tweet us @NKF_Nephpros. Thank you for tuning in!


More episodes

Load more